Studies of Novel Coronavirus Disease 19 (COVID-19) Pandemic: A Global Analysis of Literature

An exponential growth of literature about novel coronavirus disease 19 (COVID-19) has been observed in the last few months. This textual analysis of 5,780 publications extracted from the Web of Science, Medline, and Scopus databases was performed to explore the current research focuses and propose further research agenda. The Latent Dirichlet allocation was used for topic modeling. Regression analysis was conducted to examine country variations in the research focuses. Results indicated that publications were mainly contributed by the United States, China, and European countries. Guidelines for emergency care and surgical, viral pathogenesis, and global responses in the COVID-19 pandemic were the most common topics. There was variation in the research approaches to mitigate COVID-19 problems in countries with different income and transmission levels. Findings highlighted the need for global research collaboration among high- and low/middle-income countries in the different stages of prevention and control the pandemic.

[1]  N. Kandel,et al.  Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries , 2020, The Lancet.

[2]  Barbara J. Hoogenboom,et al.  Publishing your work in a journal: understanding the peer review process. , 2012, International journal of sports physical therapy.

[3]  Ludo Waltman,et al.  Text mining and visualization using VOSviewer , 2011, ArXiv.

[4]  H. Croker,et al.  School Closure and Management Practices During Coronavirus Outbreaks Including COVID-19: A Rapid Narrative Systematic Review , 2020 .

[5]  S. Tian,et al.  Coronavirus disease 2019: a bibliometric analysis and review. , 2020, European review for medical and pharmacological sciences.

[6]  B. Tran,et al.  Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry , 2020, Brain, Behavior, and Immunity.

[7]  R. Alizadeh-Navaei,et al.  The Role of Hydroxychloroquine in the Age of COVID-19: A Periodic Systematic Review and Meta-Analysis , 2020 .

[8]  Ravi Philip Rajkumar,et al.  COVID-19 and mental health: A review of the existing literature , 2020, Asian Journal of Psychiatry.

[9]  R. Ho,et al.  Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China , 2020, International journal of environmental research and public health.

[10]  Nan-shan Zhong,et al.  Cardiovascular comorbidity and its impact on patients with COVID-19 , 2020, European Respiratory Journal.

[11]  Yuh-Lih Chang,et al.  Potential therapeutic agents against COVID-19: What we know so far , 2020, Journal of the Chinese Medical Association : JCMA.

[12]  D. Rajgor,et al.  The many estimates of the COVID-19 case fatality rate , 2020, The Lancet Infectious Diseases.

[13]  Huixia Yang,et al.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records , 2020, The Lancet.

[14]  Bach Tran,et al.  Is returning to work during the COVID-19 pandemic stressful? A study on immediate mental health status and psychoneuroimmunity prevention measures of Chinese workforce , 2020, Brain, Behavior, and Immunity.

[15]  C. Murray Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months , 2020, medRxiv.

[16]  R. Viner,et al.  School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review , 2020, The Lancet Child & Adolescent Health.

[17]  Mohamad Chahrour,et al.  A Bibliometric Analysis of COVID-19 Research Activity: A Call for Increased Output , 2020, Cureus.

[18]  Novel Coronavirus Pneumonia Emergency Response Epidemiol Team [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[19]  E. Holmes,et al.  The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.

[20]  T. Lancet Redefining vulnerability in the era of COVID-19 , 2020, The Lancet.

[21]  M. Fain,et al.  SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes , 2020, GeroScience.

[22]  A. Lovato,et al.  Clinical Presentation of COVID-19: A Systematic Review Focusing on Upper Airway Symptoms , 2020, Ear, nose, & throat journal.

[23]  R. Alizadeh-Navaei,et al.  Hydroxychloroquine Versus COVID-19: A Rapid Systematic Review and Meta-Analysis , 2020, medRxiv.

[24]  Vijay K. Sharma,et al.  A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak , 2020, Brain, Behavior, and Immunity.

[25]  Sharon Einav,et al.  A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 , 2020, Journal of Critical Care.

[26]  D. Adam Special report: The simulations driving the world’s response to COVID-19 , 2020, Nature.

[27]  B. Allegranzi,et al.  Managing COVID-19 in Low- and Middle-Income Countries. , 2020, JAMA.

[28]  C. Berterö Guidelines for writing a commentary , 2016, International journal of qualitative studies on health and well-being.

[29]  Heidi Ledford Chloroquine hype is derailing the search for coronavirus treatments , 2020, Nature.

[30]  D. Cucinotta,et al.  WHO Declares COVID-19 a Pandemic , 2020, Acta bio-medica : Atenei Parmensis.

[31]  K. To,et al.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan , 2020, Emerging microbes & infections.

[32]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[33]  Ludo Waltman,et al.  Visualizing Bibliometric Networks , 2014 .

[34]  Qianyun Liu,et al.  Emerging coronaviruses: Genome structure, replication, and pathogenesis , 2020, Journal of medical virology.

[35]  Jeffrey K Aronson,et al.  Chloroquine and hydroxychloroquine in covid-19 , 2020, BMJ.

[36]  Michael I. Jordan,et al.  Latent Dirichlet Allocation , 2001, J. Mach. Learn. Res..

[37]  F. Rahim,et al.  Bibliometric Analysis of Global Scientific Research on SARSCoV-2 (COVID-19) , 2020, medRxiv.

[38]  B. Liang,et al.  Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis , 2020, Journal of Infection.

[39]  Shibo Jiang,et al.  Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees , 2020, Nature.

[40]  Zhaofeng Chen,et al.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[41]  Bach Tran,et al.  A longitudinal study on the mental health of general population during the COVID-19 epidemic in China , 2020, Brain, Behavior, and Immunity.

[42]  M. Fain,et al.  Correction to: SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes , 2020, GeroScience.

[43]  A. Wilder-Smith,et al.  Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak , 2020, Journal of travel medicine.